Systemic candidiasis in cardiac surgery patients

European Journal of Cardio-thoracic Surgery

Volumn 11, Issue 4, 1997, Pages 728-731

  Michalopoulos, A ^a   Kriaras, J ^a   Geroulanos, S ^a  

^a ONASSIS CARDIAC SURGERY CENTER   (Greece)

Author keywords

Bypass; Cardiac surgery; Fluconazole; ICU; Systemic candidiasis

Indexed keywords

FLUCONAZOLE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANDIDIASIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEART SURGERY; HUMAN; INTENSIVE CARE UNIT; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; OPEN HEART SURGERY; PRIORITY JOURNAL; SEPSIS; SYSTEMIC DISEASE;

EID: 0030990954     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1010-7940(96)01071-8     Document Type: Article

References (23)

1. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20:864-874.
2. Bjorkholm M. Chemoprophylaxis of fungal infections in neutropenic patients. Ann Oncol 1994;5:571-574.
3. British Society of deep Candida infection in surgical and intensive care unit patients. British Society for Antimicrobial Chemotherapy Working Party. Intensive Care Med 1994;20:522-528.
4. Dawson-Saunders B, Trapp R. Basic and clinical biostatistics. A Lange medical book, second ed. Englewood Cliffs, NJ: Prentice-Hall, 1994:99-125.
5. Dixon WJ. BMDP statistical software manual. Berkeley, CA: University of California Press, 1990;55-59.
6. Edwards JE. Invasive Candida infections. Evolution of a fungal pathogen. N Engl J Med 1991;324:1059-1062.
7. Egger T, Gratwohl A, Tichelli A et al. Comparison of fluconazole with oral polyenes in the prevention of fungal infections in neutropenic patients. A prospective, randomized, single-center study. Support Care Cancer 1995;3:139-146.
8. Fraser VJ, Jones M, Dunkel J, Storfer S, Medoff G, Dunagan WC. Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality. Clin Infect Dis 1992;15:414-421.
9. Funai N, Shimamoto Y, Tokunaga O, Sugihara W, Yamaguchi M. Ten-year survey of incidence of infection as a cause of death in hematologic malignancies: study of 90 autopsied cases. Acta Haematol 1995;93:25-30.
10. Ibelings MS, Bruining HA. Dutch results of the European study of prevalence of infection during intensive care (EPIIC). Nature of the infections. Ned Tijdschr Geneeskd 1994;138:2244-2247.
11. Kunova A, Trupl J, Spanik S et al. Candida glabrata, Candida krusei, non-albicans Candida spp., and other association with the use of fluconazole. Chemotherapy 1994;41:39-44.
12. Naef M, von-Overbeck J, Seiler C, Baer HU. Candida infection in surgery. Chirurg 1994;65:785-790.
13. Nucci M, Schechter M, Spector N et al. Antibiotic regimen as an independent risk factor for disseminated fungal infections in neutropenic patients in Brazil. Trans R Soc Trop Med Hyg 1995;89:107-110.
14. Pfaller MA. Epidemiology and control of fungal infections. Clin Infect Dis 1994;19(1):S8-13.
15. Schuler U, Ehninger G. New approaches to the prophylaxis and treatment of bacterial and fungal infections in allogeneic marrow transplant recipients. Bone Marrow Transplant 1994;14(4):61-65.
16. Slavin MA, Osborne B, Adams R et al. Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation: a prospective, randomized, double-blind study. J Infect Dis 1995;171:1545-1552.
17. Spencer RC. Epidemiology of infection in ICUs. Intensive Care Med 1994;20:S2-6.
18. Sugar AM. Use of amphotericin B with azole antifungal drugs: what are we doing? Antimicrob Agents Chemother 1995;39:1907-1912.
19. Taylor GD, Buchanan-Cell-M, Kirkland T, McKenzie M, Wiens R. Trends and sources of nosocomial fungaemia. Mycoses 1994;37:187-190.
20. Tollemar J, Hockerstedt K, Ericzon BG, Jalanko H, Ringden O. Prophylaxis with liposomal amphotericin B prevents fungal infections in liver transplant recipients: long-term results of a randomized, placebo-controlled trial. Transplant Proc 1995;27:1195-1198
21. Trilla A. Epidemiology of nosocomial infections in adult intensive care units. Intensive Care Med 1994;20:S1-S4.
22. Van Den Anker JN, Van Popele NML, Sauer PJJ. Antifungal agents in neonatal systemic candidiasis. Antimicrob Agents Chemother 1995;39:1391-1397.
23. Wenzel RP, Pfaller MA. Candida species: emerging hospital bloodstream pathogens. Infect Control Hosp Epidemiol 1991;12:523-524.